Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

By: Business Wire

 

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  237.74
+0.16 (0.07%)
AAPL  273.94
+0.99 (0.36%)
AMD  248.65
+0.69 (0.28%)
BAC  52.58
-0.29 (-0.56%)
GOOG  278.13
-0.99 (-0.35%)
META  608.14
-1.75 (-0.29%)
MSFT  508.04
+4.75 (0.94%)
NVDA  188.44
+1.57 (0.84%)
ORCL  222.25
+4.68 (2.15%)
TSLA  403.86
+1.87 (0.47%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS